Loss of ZBTB24 impairs nonhomologous end-joining and class-switch recombination in patients with ICF syndrome

  • Angela Helfricht
    Department of Human Genetics, Leiden University Medical Center, Leiden, Netherlands 1
  • Peter E. Thijssen
    Department of Human Genetics, Leiden University Medical Center, Leiden, Netherlands 1
  • Magdalena B. Rother
    Department of Human Genetics, Leiden University Medical Center, Leiden, Netherlands 1
  • Rashmi G. Shah
    CHU de Québec Research Centre (site CHUL) and Laboratory for Skin Cancer Research and Axe Neuroscience, Université Laval, Québec, Canada 2
  • Likun Du
    Department of Biosciences and Nutrition, Karolinska Institute, Solna, Sweden 3
  • Sanami Takada
    Laboratory for Pediatric Immunology, Department of Pediatrics, Willem Alexander Children’s Hospital, Leiden University Medical Center, Leiden, Netherlands 4
  • Mélanie Rogier
    Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France 5
  • Jacques Moritz
    Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France 5
  • Hanna IJspeert
    Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands 9
  • Chantal Stoepker
    Department of Human Genetics, Leiden University Medical Center, Leiden, Netherlands 1
  • Monique M. van Ostaijen-ten Dam
    Laboratory for Pediatric Immunology, Department of Pediatrics, Willem Alexander Children’s Hospital, Leiden University Medical Center, Leiden, Netherlands 4
  • Vincent Heyer
    Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France 5
  • Martijn S. Luijsterburg
    Department of Human Genetics, Leiden University Medical Center, Leiden, Netherlands 1
  • Anton de Groot
    Department of Human Genetics, Leiden University Medical Center, Leiden, Netherlands 1
  • Rianca Jak
    Department of Human Genetics, Leiden University Medical Center, Leiden, Netherlands 1
  • Gwendolynn Grootaers
    Department of Human Genetics, Leiden University Medical Center, Leiden, Netherlands 1
  • Jun Wang
    Department of Human Genetics, Leiden University Medical Center, Leiden, Netherlands 1
  • Pooja Rao
    ServiceXS B.V., Leiden, Netherlands 10
  • Alfred C.O. Vertegaal
    Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands 11
  • Maarten J.D. van Tol
    Laboratory for Pediatric Immunology, Department of Pediatrics, Willem Alexander Children’s Hospital, Leiden University Medical Center, Leiden, Netherlands 4
  • Qiang Pan-Hammarström
    Department of Biosciences and Nutrition, Karolinska Institute, Solna, Sweden 3
  • Bernardo Reina-San-Martin
    Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France 5
  • Girish M. Shah
    CHU de Québec Research Centre (site CHUL) and Laboratory for Skin Cancer Research and Axe Neuroscience, Université Laval, Québec, Canada 2
  • Mirjam van der Burg
    Laboratory for Pediatric Immunology, Department of Pediatrics, Willem Alexander Children’s Hospital, Leiden University Medical Center, Leiden, Netherlands 4
  • Silvère M. van der Maarel
    Department of Human Genetics, Leiden University Medical Center, Leiden, Netherlands 1
  • Haico van Attikum
    Department of Human Genetics, Leiden University Medical Center, Leiden, Netherlands 1

説明

<jats:p>The autosomal recessive immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome is a genetically heterogeneous disorder. Despite the identification of the underlying gene defects, it is unclear how mutations in any of the four known ICF genes cause a primary immunodeficiency. Here we demonstrate that loss of ZBTB24 in B cells from mice and ICF2 patients affects nonhomologous end-joining (NHEJ) during immunoglobulin class-switch recombination and consequently impairs immunoglobulin production and isotype balance. Mechanistically, we found that ZBTB24 associates with poly(ADP-ribose) polymerase 1 (PARP1) and stimulates its auto-poly(ADP-ribosyl)ation. The zinc-finger in ZBTB24 binds PARP1-associated poly(ADP-ribose) chains and mediates the PARP1-dependent recruitment of ZBTB24 to DNA breaks. Moreover, through its association with poly(ADP-ribose) chains, ZBTB24 protects them from degradation by poly(ADP-ribose) glycohydrolase (PARG). This facilitates the poly(ADP-ribose)-dependent assembly of the LIG4/XRCC4 complex at DNA breaks, thereby promoting error-free NHEJ. Thus, we uncover ZBTB24 as a regulator of PARP1-dependent NHEJ and class-switch recombination, providing a molecular basis for the immunodeficiency in ICF2 syndrome.</jats:p>

収録刊行物

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ